Sens. Shaheen, Capito Lead Bipartisan IMPACT Act to Reform Opioid Use Disorder Medication Holding Period for Providers
November 24, 2021
November 24, 2021
WASHINGTON, Nov. 24 -- Sen. Jeanne Shaheen, D-New Hampshire, issued the following news release:
U.S. Senators Jeanne Shaheen (D-NH) and Shelley Moore Capito (R-WV) introduced bipartisan legislation that would increase the amount of time a physician can hold long-acting injectable (LAI) buprenorphine - a form of medication for opioid use disorders - from a specialty pharmacy. U.S. Representatives Madeleine Dean (PA-04), Victoria Spartz (IN-05), Mary Gay Scanlon (PA-05) and Brian Fitz . . .
U.S. Senators Jeanne Shaheen (D-NH) and Shelley Moore Capito (R-WV) introduced bipartisan legislation that would increase the amount of time a physician can hold long-acting injectable (LAI) buprenorphine - a form of medication for opioid use disorders - from a specialty pharmacy. U.S. Representatives Madeleine Dean (PA-04), Victoria Spartz (IN-05), Mary Gay Scanlon (PA-05) and Brian Fitz . . .